Skip to main content
. 2019 Oct 15;9:1055. doi: 10.3389/fonc.2019.01055

Figure 1.

Figure 1

PD-L1 (A), PD-1 (B), and CD8 (C) expression frequency. (A) Overall, 90.6% of thymic epithelial tumors (TETs) exhibited immunopositivity for PD-L1 at cut-off of more than 1%. High PD-L1 expression was observed in 39.0% (cut-off over 50%). (B) Overall, 53.6% of TETs showed immunopositivity for PD-1. (C) Overall, 27% of thymic carcinoma samples exhibited immunopositivity for CD8.